BSE: SOLARA - Solara Active Pharma Sciences Limited

Rentabilité sur six mois: -36.88%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Solara Active Pharma Sciences Limited


À propos de l'entreprise Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India.

plus de détails
The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

ISIN INE624Z01016
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4382
Дивиденд ао 3.04
Сайт https://www.solara.co.in
Цена ао 479.75
Changement de prix par jour: 0% (479.75)
Changement de prix par semaine: -8.39% (523.7)
Changement de prix par mois: -4.78% (503.85)
Changement de prix sur 3 mois: -35.33% (741.85)
Changement de prix sur six mois: -36.88% (760)
Changement de prix par an: +22.62% (391.25)
Evolution du prix sur 3 ans: -25.35% (642.706)
Evolution du prix sur 5 ans: +14.37% (419.485)
Evolution des prix sur 10 ans: 0% (479.75)
Evolution des prix depuis le début de l'année: -30.16% (686.95)

Sous-estimation

Nom Signification Grade
P/S 1.2 9
P/BV 1.59 8
P/E 0 0
EV/EBITDA 14.19 7
Total: 5.25

Efficacité

Nom Signification Grade
ROA, % -21.63 0
ROE, % -46.55 0
Total: 0.8333

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0.6 6
Total: 1.33

Devoir

Nom Signification Grade
Debt/EBITDA 6.39 0
Total: 5.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -2.31 0
Rentabilité Ebitda, % -43.46 0
Rentabilité EPS, % -468.02 0
Total: 0



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Poorvank Purohit MD, CEO & Director N/A 1979 (46 années)
Mr. Mohan Muthunarayanan COO & Executive Director N/A
Mr. Suddapalli Murali Krishna Company Secretary, Compliance Officer & Chief Investor Relations Officer N/A
Mr. Arun Kumar Pillai B.Com. Founder & Non-Executive Director N/A 1961 (64 année)
Mr. V. Sundara Moorthy Chief Quality Officer N/A
Mr. Arun Kumar Baskaran Chief Financial Officer N/A
Dr. Hero Velladurai Chief Scientific Officer N/A

Adresse: India, Chennai, Admin Block 27 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.solara.co.in